Home » Topics » Regulatory » EMA

EMA
RSS

Prefilled syringes of Relistor approved in U.S., E.U. and Canada

Oct. 1, 2010

Novartis' H5N1 vaccine Aflunov for adults gets positive opinion in E.U.

Sep. 29, 2010

CHMP recommends approval of AstraZeneca's ticagrelor

Sep. 29, 2010

CHMP finds no causal relationship between GSK's Pandemrix vaccine and narcolepsy

Sep. 28, 2010

Rosiglitazone-containing diabetes medicines suspended in Europe, restricted in U.S.

Sep. 28, 2010

CHMP recommends approval of TOBI Podhaler for cystic fibrosis

Sep. 28, 2010

CHMP recommends approval of Tasigna in E.U. as first-line therapy for Ph+ CML

Sep. 28, 2010

FDA and EMA to review vandetanib for advanced medullary thyroid cancer

Sep. 27, 2010

EMA updates nevirapine label for patients with HIV-1 infection

Sep. 21, 2010

Novartis Europharm withdraws Rasival MAA for essential hypertension

Sep. 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.